Now available OMVOH™

OMVOH™ (mirikizumab-mrkz) injection, for intravenous or subcutaneous use, is an interleukin-23 antagonist indicated for the treatment of moderately to severely active ulcerative colitis in adults.

Please see full prescribing information.